IMPROVE

IMPROVE

IMPROVE  Start and End dates: 2016 to 2020 Source of Funding: DFID/MRC/Wellcome Trust and European and Developing Countries Clinical Trials Partnership (EDCTP) ($1.8m) The overall aim of the study is to provide the WHO with definitive evidence to determine whether...
IMPROVE

IMPROVE2

IMPROVE 2  IPTp with dihydroartemisinin-piperaquine and single-course azithromycin for malaria, sexually transmitted and reproductive tract infections in HIV-infected pregnant women in Kenya and Malawi: a multi-centre, 3-arm placebo-controlled trial Start and End...
REVAMP

REVAMP

REVAMP  Randomized controlled trial of the effect of intravenous iron on anemia in Malawian pregnant women Start and End dates: 2017 to 2022 Source of Funding: Bill & Melinda Gates Foundation ($1.6 million) An individual-randomized Phase III, open-label clinical...
REVAMP

REVAMP Accept

REVAMP Accept  Randomized controlled trial of the effect of intravenous iron on anaemia in Malawian pregnant women (REVAMP): Feasibility and Acceptability Start and End dates: 2017 to 2022 Source of Funding: Bill & Melinda Gates Foundation ($20,000) This is a...
REVAMP

REVAMP Observe

REVAMP Observe  Randomized controlled trial of the effect of intravenous iron on anaemia in Malawian pregnant women (REVAMP): Observation Cohort Start and End dates: 2018 to 2022 Source of Funding: Bill & Melinda Gates Foundation ($0.75 million) This is a cohort study...
REVAMP

REVAMP TT

REVAMP TT  Randomized controlled trial of the effect of intravenous iron on anaemia in Malawian pregnant women (REVAMP): Third Trimester Start and End dates: 2020 to 2024 Source of Funding: Bill & Melinda Gates Foundation ($4.6 million) This is an open-label clinical...